Paul Gomes has been with Ora since 1998. He has held a number of roles, culminating in his current position of Vice President of Allergy & Blepharitis. He oversees a team of 28 and consults with clients to design cost- and time-efficient strategies for product clinical development. He provides regulatory, clinical study design and operations, data analysis, and marketing consultation, and also oversees profitability. He manages staff utilization and project revenue, and acts as primary liaison with clients, vendors, senior management and investigator sites as needed.
The author of numerous peer-review publications, Paul has led protocol design, operational execution, and data interpretation, and has overseen multi-center trials both in the U.S. and internationally, regularly interfacing with European, Japanese, and U.S. regulatory authorities. He also is a sought-after presenter at industry conferences.
He leads the Allergy Department’s research & development. His areas of clinical research experience include ocular allergy, nasal allergy, ocular redness relief, blepharitis, and eyelid swelling. He has overseen development programs from initial clinical proof to concept through Phase IV for many products, including Zaditen, Pataday, Alaway, Bepreve, Lastacaft, Pazeo, Zerviate and Lumify, verifying their efficacy and safety, as well as PK and marketing trials.
Earlier positions at Ora include Director of Allergy, Senior Manager of Allergy, Manager of Basic Sciences & Medical Writing, and Clinical Research Associate.
Prior to his time at Ora, Paul was a University of Massachusetts Research Assistant while he was a student there, focusing on the induction of cytochrome P450 1A and identifying novel nuclear hormone receptor associated proteins.
Paul earned a Master of Science in Biomedical Sciences at the University of Massachusetts Medical Center and a Bachelor of Science in Biochemistry from the University of Rochester in New York.
